EFFICACY AND SAFETY OF TOFACITINIB IN ULCERATIVE COLITIS (Review)

Koloproktologia
doi 10.33878/2073-7556-2018-0-3-94-102
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Russian Association of Coloproctology

Related search

Efficacy and Safety of Biologic Agents and Tofacitinib in Moderate-To-Severe Ulcerative Colitis: A Systematic Overview of Meta-Analyses

United European Gastroenterology Journal
OncologyGastroenterology
2019English

Systematic Review: Safety of Mesalazine in Ulcerative Colitis

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Randomized Trial of Tofacitinib in Active Ulcerative Colitis: Analysis of Efficacy Based on Patient-Reported Outcomes

BMC Gastroenterology
MedicineGastroenterology
2015English

Profile of Tofacitinib in the Treatment of Ulcerative Colitis: An Evidence-Based Review of Recent Data

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2019English

Combination Therapy With Vedolizumab and Tofacitinib in a Patient With Ulcerative Colitis and Spondyloarthropathy

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2019English

Efficacy and Safety of Rectal 5-Aminosalicylic Acid Versus Corticosteroids in Active Distal Ulcerative Colitis: A Systematic Review and Network Meta-Analysis

Scientific Reports
Multidisciplinary
2017English

Editorial: Tofacitinib and Biologics for Moderate-To-Severe Ulcerative Colitis-What Is Best in Class?

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Efficacy and Safety of Abrilumab in a Randomized, Placebo-Controlled Trial for Moderate to Severe Ulcerative Colitis

Gastroenterology
HepatologyGastroenterology
2019English

Efficacy, Safety and Cost Analyses in Ulcerative Colitis Patients Undergoing Granulocyte and Monocyte Adsorption or Receiving Prednisolone

BMC Gastroenterology
MedicineGastroenterology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy